部分纯化疫苗在一名志愿者身上诱导出针对皮肤利什曼病的保护性免疫。 - Suppr | 超能文献

Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer.

作者信息

Monjour L, Monjour E, Vouldoukis I, Ogunkolade B W, Frommel D

出版信息

Lancet. 1986 Jun 28;1(8496):1490. doi: 10.1016/s0140-6736(86)91516-3.

DOI:10.1016/s0140-6736(86)91516-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer.部分纯化疫苗在一名志愿者身上诱导出针对皮肤利什曼病的保护性免疫。

Lancet. 1986 Jun 28;1(8496):1490. doi: 10.1016/s0140-6736(86)91516-3.

2

Second-generation vaccines against leishmaniasis.第二代抗利什曼病疫苗。

Trends Parasitol. 2005 May;21(5):244-9. doi: 10.1016/j.pt.2005.03.006.

3

Vaccination against Leishmania infections.针对利什曼原虫感染的疫苗接种。

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):201-26. doi: 10.2174/1568008023340631.

4

Heterologous protection in murine cutaneous leishmaniasis.小鼠皮肤利什曼病中的异源保护作用。

Immunol Cell Biol. 1987 Oct;65 Pt 5:387-92. doi: 10.1038/icb.1987.44.

5

Further trials of a vaccine against American cutaneous leishmaniasis.

Trans R Soc Trop Med Hyg. 1986;80(6):1001. doi: 10.1016/0035-9203(86)90296-8.

6

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.用编码免疫显性利什曼原虫（硕大利什曼原虫）主要抗原的质粒混合物进行基于DNA的疫苗接种，可使BALB/c小鼠获得完全保护。

Vaccine. 2009 Jan 1;27(1):99-106. doi: 10.1016/j.vaccine.2008.10.013. Epub 2008 Oct 23.

7

Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.使用颗粒状利什曼原虫抗原或编码LACK的DNA进行鼻内接种以预防皮肤利什曼病。

Infect Immun. 2004 Aug;72(8):4521-7. doi: 10.1128/IAI.72.8.4521-4527.2004.

8

Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.实验性利什曼病的预防性免疫。IV. 皮下免疫可阻止针对致命性硕大利什曼原虫感染的保护性免疫的诱导。

J Immunol. 1985 Sep;135(3):2095-101.

9

The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection.利什曼原虫热休克蛋白20（Leishmania HSP20）在自然感染过程中具有抗原性，但作为DNA疫苗时，它并不能保护BALB/c小鼠免受实验性亚马逊利什曼原虫（L. amazonensis）感染。

J Biomed Biotechnol. 2008;2008:695432. doi: 10.1155/2008/695432.

10

Immunoprophylaxis against Leishmania infections with a semi-purified antigen.

Trans R Soc Trop Med Hyg. 1986;80(6):1013. doi: 10.1016/0035-9203(86)90314-7.

引用本文的文献

1

In vitro assessment of anti-Leishmania immunity of man acquired with a vaccine.

Experientia. 1988 Jan 15;44(1):56-7. doi: 10.1007/BF01960244.

2

South American leishmaniasis.南美洲利什曼病

J R Soc Med. 1988 Feb;81(2):110-1. doi: 10.1177/014107688808100222.